[go: up one dir, main page]

DK0555446T3 - Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors - Google Patents

Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors

Info

Publication number
DK0555446T3
DK0555446T3 DK92918251T DK92918251T DK0555446T3 DK 0555446 T3 DK0555446 T3 DK 0555446T3 DK 92918251 T DK92918251 T DK 92918251T DK 92918251 T DK92918251 T DK 92918251T DK 0555446 T3 DK0555446 T3 DK 0555446T3
Authority
DK
Denmark
Prior art keywords
antagonists
prevention
treatment
partial agonists
ht1a receptor
Prior art date
Application number
DK92918251T
Other languages
English (en)
Inventor
Jonathan Turner
Belinda Cole
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6443608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0555446(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0555446T3 publication Critical patent/DK0555446T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92918251T 1991-08-31 1992-08-28 Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors DK0555446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4135551A DE4135551A1 (de) 1991-08-31 1991-08-31 Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen
PCT/DE1992/000720 WO1993004681A1 (de) 1991-08-31 1992-08-28 VERWENDUNG VON ANTAGONISTEN ODER PARTIELLEN AGONISTEN AM 5-HT1a-REZEPTOR ZUR BEHANDLUNG UND PRÄVENTION VON KOGNITIVEN STÖRUNGEN

Publications (1)

Publication Number Publication Date
DK0555446T3 true DK0555446T3 (da) 2000-01-31

Family

ID=6443608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918251T DK0555446T3 (da) 1991-08-31 1992-08-28 Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors

Country Status (10)

Country Link
EP (1) EP0555446B1 (da)
JP (1) JPH06501713A (da)
AT (1) ATE182467T1 (da)
CA (1) CA2093009A1 (da)
DE (2) DE4135551A1 (da)
DK (1) DK0555446T3 (da)
ES (1) ES2135412T3 (da)
GR (1) GR3031514T3 (da)
HU (1) HUT63331A (da)
WO (1) WO1993004681A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223153D0 (en) * 1992-11-05 1992-12-16 Wyeth John & Brother Ltd Piperazine derivatives
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
EP0710481A1 (en) * 1994-11-02 1996-05-08 Duphar International Research B.V Use of flesinoxan for cognition enhancement
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
MXPA00010805A (es) 1998-05-06 2002-05-08 Univ Duke Metodo para el tratamiento de sindromes de la vejiga y del tracto urinario inferior.
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
GT200600416A (es) 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
PE20070523A1 (es) 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
GT200600414A (es) 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
US20130064770A1 (en) 2010-05-28 2013-03-14 Ge Healthcare Limited Radiolabeled compounds and methods thereof
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4897399A (en) * 1988-04-20 1990-01-30 Ciba-Geigy Corp. Heterotertracyclic lactam derivatives, pharmaceutical compositions, and method of treating impaired memory and learning
GB2222768B (en) * 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
WO1993004681A1 (de) 1993-03-18
CA2093009A1 (en) 1993-03-01
DE59209728D1 (de) 1999-09-02
EP0555446A1 (de) 1993-08-18
JPH06501713A (ja) 1994-02-24
DE4135551A1 (de) 1993-03-04
ATE182467T1 (de) 1999-08-15
EP0555446B1 (de) 1999-07-28
GR3031514T3 (en) 2000-01-31
HU9301250D0 (en) 1993-07-28
ES2135412T3 (es) 1999-11-01
HUT63331A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
DK0555446T3 (da) Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors
AR219565A1 (es) Procedimiento para la preparacion de compuestos de 4-(di-n-propil)amino-1,3,4,5-tetrahidrobenc(c1d)indol y sus sales
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
MX9102501A (es) Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion.
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
ES2036192T3 (es) Derivados del acido (met)-acrilico, que contienen grupos uretano, de triciclo (5.2.1.0.2.6) decano.
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
NO892894D0 (no) Nye kondenserte heterocykliske forbindelser.
NO943347L (no) Halichondriner og beslektede forbindelser
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
MX9203505A (es) N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos.
IT7819569A0 (it) Procedimento per la protezione di documenti dalla contraffazione, e documento cosi' ottenuto.
NO157135C (no) Fremgangsmaate til termisk spalting av 1,2-dikloretan.
SE9003248L (sv) Anordning foer att vaenda foeremaal, t ex i samband med avsyning av desamma
MX9202656A (es) Compuestos de tiadiazabiciclooctano o tiadiazabicicloocteno, procedimiento para su obtencion y composicion herbicida que los contiene.
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
DK359887D0 (da) Termohaerdnende materialer indeholdende acryl-polymere, som er praktisk taget fri for aeaktive hydrogengrupperae
ES2000369A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
DK165689C (da) 1,5-disubstituerede imidazolderivater, fremgangsmaade til fremstilling af saadanne forbindelser, fungicidt praeparat indeholdende saadanne forbindelser samt anvendelse af saadanne forbindelser som fungicider
FI875538A7 (fi) Uudet maleimideihin perustuvat yhdisteet ja uudet, niitä sisältävät valolla kovettuvat koostumukset.
NO910991D0 (no) Fremgangsmaate og apparat som benyttes for omdanning av problemavfall til ufarlig aggregat.
DK204891D0 (da) Hidtil ukendte cyanoalkylbenzamidderivater, fremgangsmaade til fremstilling deraf, samt anvendelse af saadanne cyanoalkylbenzamidderivater som mellemprodukt ved fremstilling af substituerede n-(imidazolinyl-methyl)-benzamider
NO885406L (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.
ES2008640A4 (es) Derivados de aminopropanol de compuestos de 3-(3-hidroxifenil)-1-propanona, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.